Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

Production of Formed Elements

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

Primary Lymphoid Organs

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Glofitamab as a salvage therapy postallogenic hematopoietic stem cell transplant in relapsed-refractory Burkitt lymphoma.

Leukemia & lymphoma·2026

Same author

Dose de-escalation of alemtuzumab in matched unrelated donor haematopoietic stem cell transplantation.

British journal of haematology·2026

Same author

CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Same author

Host versus graft HLA-DP1 mismatching promotes graft versus host disease.

Bone marrow transplantation·2023

Same author

An open-source, expert-designed decision tree application to support accurate diagnosis of myeloid malignancies.

EJHaem·2022

Same author

Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.

Blood advances·2021

Search research articles

Related Experiment Video

Updated: May 11, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Myeloproliferative neoplasms.

Amy Publicover¹, Patrick Medd

¹Department of Haematology, University Hospital Southampton. UK.

Clinical Medicine (London, England)

|May 18, 2013

Summary

Myeloproliferative neoplasms linked to JAK2 mutations are complex. Research is ongoing to understand additional mutations and develop targeted therapies for these chronic blood cancers.

Area of Science:

Hematology
Oncology
Molecular Biology

Background:

Myeloproliferative neoplasms (MPNs) associated with Janus Kinase 2 (JAK2) mutations represent a diverse set of blood disorders.
The precise genetic landscape and additional mutations driving specific clinical phenotypes in JAK2-mutated MPNs require further elucidation.
Unlike BCR-ABL in chronic myeloid leukemia, JAK2 has essential physiological functions, complicating the development of targeted therapies.

Purpose of the Study:

To review the current understanding of JAK2-mutated myeloproliferative neoplasms.
To highlight the challenges in developing targeted therapies due to the complexity of mutations and JAK2's physiological role.
To discuss current treatment strategies and the impact of managing thrombotic risk.

Main Methods:

Keywords:

JAK2 myelofibrosis myeloproliferative polycythaemia thrombocytosis

More Related Videos

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Related Experiment Videos

Last Updated: May 11, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Literature review of existing research on JAK2 mutations in MPNs.
Analysis of the genetic basis and clinical manifestations of these disorders.
Evaluation of current therapeutic approaches and their efficacy.

Main Results:

JAK2-mutated MPNs are heterogeneous, with additional mutations influencing disease presentation.
Targeted therapy development is challenging due to JAK2's normal functions.
Current treatments largely rely on established agents, with significant progress in managing thrombotic risk.

Conclusions:

Improved survival rates in essential thrombocythemia (ET) and polycythemia vera (PV) are attributed to better thrombotic risk management, transforming them into chronic diseases.
Continued research into the molecular drivers of JAK2-mutated MPNs is crucial for advancing targeted treatment options.
Despite challenges, the field is moving towards better management and understanding of these complex hematological malignancies.